Antibody Testing Market 2022
The global Antibody Testing Market is stipulated to witness a CAGR of 7.7% and reach US$ 15.6 Bn by the year 2021-2031. Digital innovation is the buzzword. As such, digital health unicorns are coming up. Digital upswinging is thus expected to take the entire healthcare vertical by storm in the next 10 years. This would be the state of the healthcare vertical in the near future.
As per Persistence Market Research’s revised industry analysis, the global antibody testing market was valued at over US$ 6.9 Bn in 2020, and is expected to exhibit a CAGR of around 7.7% over the forecast period (2021-2031).
Burden of chronic diseases is expected to continue growing over the coming years, which will be a major reason for the expansion of market size. With diagnosis being the first step to any kind of treatment, test kits will be imperative to diagnose any condition to start related treatment.
Get Free Sample Copy Of Antibody Testing Market Report@ https://www.persistencemarketresearch.com/samples/31930
As per the International Diabetes Federation, there were approximately 463 million adults aged 20 to 79 years in 2019 living with diabetes globally, with a majority of them suffering from type 2 diabetes. This number is expected to rise to 700 million by 2045. This increasing number will create huge demand for testing kits. Furthermore, constant investments by big market players to launch novel diagnostic kits to cater to unmet demand is also a positive factor aiding antibody testing industry growth.
Advancements in technology have caused disruptions everywhere, and the field of diagnostics has not remained untouched by this. Growing demand for tests without compromising on the quality and accuracy of the results has resulted in the automation of many processes. Rapid antibody testing kits are very much part of this growing automation to provide swift, yet accurate results. Not only technology advancements in lab automation, but also in immunoassays, will create opportunities for providers of antibody testing products.
- Thermo Fisher Scientific
- Abbott Laboratories
- Bio-Rad Laboratories, Inc.
- Beckton, Dickinson and Company
- F. Hoffmann-La Roche
- Agilent Technologies
- Zeus Scientific
- Abcam PLC
- Trinity Biotech
- Throw (Biokit)
- Meridian Bioscience
- Bio-Techne (R&D Systems)
Look Through The “Methodology” Employed@ https://www.persistencemarketresearch.com/methodology/31930
Key Takeaways from Market Study
- By product type, serological test kits are expected to hold over 42% market value share by the end of 2031, primarily because of the presence of key market players for production worldwide.
- Based on indication, infectious diseases are leading with over 21% market share, owing to extensive research opportunities in infection diagnosis and drug discovery.
- Diagnostic laboratories will dominate the end-user segment with a share of around 40%, due to increasing number of molecular biology companies focusing on infection diagnostics after the onset of COVID-19.
- By region, North America is slated to be the largest market with a value share of 35% at the end of the forecast period.
“Advancements in technology and application of antibody testing in drug discovery are anticipated to propel demand for antibody testing as a measure for disease detection and prevention,” says an analyst of Persistence Market Research.
Acquisitions, mergers, expansions, and product launches are the key strategies being adopted by manufacturers to expand their consumer base across geographies.
- December, 2018: ThermoFisher Scientific received FDA clearance for its de novo submission of the Thermo Scientific QMS Plazomicin Immunoassay, the first of its kind for complementary diagnostic immunoassays.
- March, 2019: BD launched a new automated flow cytometry system named BD FACSDuet™. The system improves efficiency by decreasing chances of errors and reducing human intervention.
What Does the Report Cover?
Persistence Market Research offers a unique perspective and actionable insights on the antibody testing market in its latest study, presenting historical demand assessment of 2016 – 2020 and projections for 2021 – 2031.
The research study is based on product (serological test kits, immunoglobulin kits, lateral flow assay kits, chemicals and reagents, and consumables), indication (pregnancy, cardiovascular diseases, autoimmune diseases, infectious diseases, oncology, endocrine diseases, diabetes, and others), and end user (hospitals, academic and research institutes, diagnostic laboratories, biopharmaceutical companies, and homecare settings), across seven key regions of the world.
Purchase Our Antibody Testing Market Report Now@ https://www.persistencemarketresearch.com/checkout/31930
Key Questions Answered in the Antibody Testing Market Report
How is the Antibody Testing Market expected to grow over the projected period?
What direction is the Antibody Testing Market expected to take in terms of volume and value during the forecast period?
What is the impact of macroeconomic factors on the Antibody Testing Market in future?
What are the key market drivers in the Antibody Testing Market?
What are significant opportunities and improvement areas for Antibody Testing Market manufacturers?
What are the key developments and trends taking over the Antibody Testing Market?
Which are the emerging countries that are expected to create significant growth opportunities in the Antibody Testing Market?
If you have any special requirements, please let us know and we will offer you the report as you want and also We Provide you Table of Content.
Medical Marijuana Market – The global medical marijuana market is anticipated to surge to US$ 76.5 Bn by 2031, reflecting a CAGR of 14.8% over the forecast period (2021-2031).
Osteoporosis Drugs Market – Global osteoporosis drugs market is anticipated to grow from an estimated US$11,226.1 Mn in 2015 to account for US$14,786.7 Mn by 2022 at a CAGR of 4.0% with good revenue.
Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – email@example.com